necrotic and apoptotic mechanisms of cell death occurred. Current pharmacological therapeutics such as dopamine precursor, L-DOPA and DA receptor agonists could ameliorate clinical symptoms, and the ...

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...

Converting one type of cell to another—for example, a skin cell to a neuron—can be done through a process that requires the ...

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...

Researchers have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder ...

Share on Pinterest An experimental stem cell therapy could help reverse corneal damage in people with a vision-threatening eye condition. Image credit: daliloveart/Getty Images. Researchers ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the long-term, drug-free remission from autoimmune diseases observed after treatment ...

A University of Minnesota research team was recently awarded a five-year, $3.8 million grant from the U.S. National Institutes of Health to develop a new cell therapy to combat Alzheimer’s disease.

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of ...

Results from a Mass Eye and Ear-led phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 ...

This may represent the longest reported remission in a patient with cancer treated with CAR-T cell therapy to date, the authors suggest. The findings are based on follow-up from a phase 1 clinical ...